What is he best known for?
The fields of study he is best known for:
- Neuron
- Internal medicine
- Neurotransmitter
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Neuroscience, Regulation of gene expression and Poison control.
His studies deal with areas such as In situ hybridization, Depression and Sensitization as well as Internal medicine.
His Endocrinology study incorporates themes from Cytokine, Immunology and Cell biology.
As part of the same scientific family, Michael O. Poulter usually focuses on Neuroscience, concentrating on Receptor and intersecting with Hormone and PDZ domain.
Michael O. Poulter performs multidisciplinary studies into Poison control and Genetics in his work.
The various areas that Michael O. Poulter examines in his GABAA receptor study include Olfactory bulb, Cortex and Interleukin 10 receptor, alpha subunit, G alpha subunit.
His most cited work include:
- Dysregulation in the Suicide Brain: mRNA Expression of Corticotropin-Releasing Hormone Receptors and GABAA Receptor Subunits in Frontal Cortical Brain Region (308 citations)
- The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. (250 citations)
- GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes (238 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Neuroscience, Internal medicine, Endocrinology, GABAA receptor and Inhibitory postsynaptic potential.
His work on Corticotropin-releasing hormone, NMDA receptor and Cytokine as part of general Internal medicine study is frequently connected to Regulation of gene expression, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His work deals with themes such as Receptor and Stressor, which intersect with Endocrinology.
He has included themes like Alpha, Neuron, G alpha subunit, Kindling and Synapse in his GABAA receptor study.
His Inhibitory postsynaptic potential research integrates issues from Neuroactive steroid, Kindling model, Epileptogenesis, Neurotransmission and Disinhibition.
His biological study deals with issues like Locus coeruleus, which deal with fields such as Receptor expression.
He most often published in these fields:
- Neuroscience (67.12%)
- Internal medicine (50.68%)
- Endocrinology (49.32%)
What were the highlights of his more recent work (between 2013-2020)?
- Neuroscience (67.12%)
- Epilepsy (13.70%)
- Excitatory postsynaptic potential (10.96%)
In recent papers he was focusing on the following fields of study:
Michael O. Poulter mainly focuses on Neuroscience, Epilepsy, Excitatory postsynaptic potential, GABAergic and Macaque.
His study in the field of Hippocampus, Premovement neuronal activity and Stimulus also crosses realms of Population and Automatic gain control.
His Hippocampus research is multidisciplinary, incorporating elements of Brain-derived neurotrophic factor, Neuroplasticity, Depression and Brain region.
His study in Epilepsy is interdisciplinary in nature, drawing from both Clinical trial, Electrophysiology and Interneuron.
His GABAergic study integrates concerns from other disciplines, such as Cerebral cortex, Gene knockdown, Cortex and Piriform cortex.
His Inhibitory postsynaptic potential research incorporates elements of Kindling model, Antagonist and Amygdala.
Between 2013 and 2020, his most popular works were:
- Neuroinflammatory targets and treatments for epilepsy validated in experimental models (73 citations)
- Gender and brain regions specific differences in brain derived neurotrophic factor protein levels of depressed individuals who died through suicide. (30 citations)
- Identification of a novel synaptic protein, TMTC3, involved in periventricular nodular heterotopia with intellectual disability and epilepsy. (20 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
